Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

Inclusion Criteria: * Patients with mild to moderate essential hypertension and whose medical condition make them eligible for treatment with Telmisartan/Telmisartan+HCTZ Exclusion Criteria: * Pre-menopausal women who had had no birth control, who are pregnant or nursing * Patients with advanced hepatic impairment, advanced renal impairment or both * Patients with functional class III or IV (NYHA) congestive heart failure (CHF), unstable angina, acute myocardial infarction, heart surgery or stroke within the previous six months * Patients with any valvular disease with hemodynamic repercussion * Patients receiving chronic administration of oral anticoagulants or digoxin * Patients with known hypersensitivity to any component in the formulation of Micardis / MicardisPlus * Patients with previous history of angioedema associated with ACE inhibitors * Patients with severe, uncontrolled hypertension or any form of secondary hypertension * Patients with any other clinical conditions which, in the opinion of the investigator, would not allow for the safe completion of the protocol